Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Thursday, August 28, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Peraton and Okta Collaborate with U.S. DoD to Advance myAuth
Vontier’s Driivz Team Up With ENAPI for EV Roaming Connectivity
Zuora and Workday Partners for Revenue Management and Financial Accuracy
Alternative Payments Debuts API to Accelerate MSP Growth Through Automation
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
Novartis Pluvicto
Novartis Pluvicto
Healthcare
Novartis Pluvicto Approved by FDA as First Targeted Radioligand Therapy
PR Newswire
-
March 25, 2022
Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) (formerly referred to as 177Lu-PSMA-617) for...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Peraton and Okta Collaborate with U.S. DoD to Advance myAuth
Vontier’s Driivz Team Up With ENAPI for EV Roaming Connectivity
Zuora and Workday Partners for Revenue Management and Financial Accuracy
Load more
